Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-11-30 Purchase | 2021-11-30 7:42 pm | KEMPHARM INC | KMPH | Pascoe Richard W Chairman | 1,500 | $7.8814 | $11,822 | 3,285 (Direct) | View |
2021-11-30 Purchase | 2021-11-30 4:10 pm | KEMPHARM INC | KMPH | Tierney David S Director | 2,000 | $7.789 | $15,578 | 3,835 (Direct) | View |
2021-11-18 Purchase | 2021-11-23 4:03 pm | KEMPHARM INC | KMPH | Mickle Travis C CEO | 2,250 | $8.2295 | $18,516 | 158,774 (Indirect Direct) | View |
2021-11-18 Purchase | 2021-11-18 4:57 pm | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 510 | $8.29 | $4,228 | 5,240 (Direct) | View |
2021-09-29 Purchase | 2021-09-29 4:10 pm | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 215 | $9.38 | $2,017 | 4,730 (Direct) | View |
2021-09-20 Purchase | 2021-09-20 5:03 pm | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 935 | $8.5865 | $8,028 | 4,515 (Direct) | View |
2021-09-01 Purchase | 2021-09-01 4:04 pm | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 230 | $9.105 | $2,094 | 3,580 (Direct) | View |
2021-08-30 Purchase | 2021-08-30 5:09 pm | KEMPHARM INC | KMPH | Mickle Travis C CEO | 5,000 | $8.9215 | $44,608 | 156,524 (Indirect Direct) | View |
2021-06-23 Purchase | 2021-06-24 4:22 pm | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 75 | $14.11 | $1,058 | 3,350 (Direct) | View |
2021-06-14 Purchase | 2021-06-14 4:37 pm | KEMPHARM INC | KMPH | Mickle Travis C CEO | 1,500 | $14.43 | $21,645 | 160,936 (Indirect Direct) | View |
2021-05-27 Purchase | 2021-05-27 5:50 pm | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 150 | $9.85 | $1,478 | 3,275 (Direct) | View |
2021-05-13 Purchase | 2021-05-17 4:42 pm | KEMPHARM INC | KMPH | Braun Samuel J 10% Owner | 10,000 | $8.55 | $85,500 | 3,070,000 (Direct) | View |
2020-08-26 Purchase | 2020-08-26 5:08 pm | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 1,000 | $0.839 | $839 | 50,000 (Direct) | View |
2020-08-18 Purchase | 2020-08-18 4:59 pm | KEMPHARM INC | KMPH | Tierney David S Director | 10,000 | $0.65317 | $6,532 | 29,372 (Direct) | View |
2020-08-18 Purchase | 2020-08-18 4:55 pm | KEMPHARM INC | KMPH | Pascoe Richard W Director | 10,000 | $0.63518 | $6,352 | 28,573 (Direct) | View |
2020-08-18 Purchase | 2020-08-18 4:48 pm | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 2,000 | $0.695 | $1,390 | 49,000 (Direct) | View |
2020-06-11 Purchase | 2020-06-11 4:10 pm | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 1,500 | $0.1923 | $288 | 47,000 (Direct) | View |
2020-06-02 Purchase | 2020-06-03 8:55 pm | KEMPHARM INC | KMPH | Mickle Travis C CEO | 110,000 | $0.189 | $20,790 | 2,551,031 (Indirect Direct) | View |
2020-05-26 Purchase | 2020-05-26 4:29 pm | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 11,500 | $0.183 | $2,105 | 45,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-02-01 Option Award | 2022-02-03 5:17 pm | N/A 2032-01-31 | KEMPHARM INC | KMPH | Sangiovanni Timothy J. VP | 50,092 | $0 | 50,092 (Direct) | View |
2022-02-01 Option Award | 2022-02-03 5:17 pm | N/A 2032-01-31 | KEMPHARM INC | KMPH | Guenther Sven VP | 83,486 | $0 | 83,486 (Direct) | View |
2022-02-01 Option Award | 2022-02-03 5:15 pm | N/A 2032-01-31 | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 83,486 | $0 | 83,486 (Direct) | View |
2022-02-01 Option Award | 2022-02-03 5:14 pm | N/A 2032-01-31 | KEMPHARM INC | KMPH | Pascoe Richard W Chairman | 127,286 | $0 | 127,286 (Direct) | View |
2022-02-01 Option Award | 2022-02-03 5:12 pm | N/A 2032-01-31 | KEMPHARM INC | KMPH | Mickle Travis C CEO | 267,156 | $0 | 267,156 (Direct) | View |
2021-12-01 Option Award | 2021-12-01 4:28 pm | N/A N/A | KEMPHARM INC | KMPH | Plooster Matthew R Director | 2,500 | $8.44 | 4,101 (Direct) | View |
2021-11-10 Option Award | 2021-11-10 9:26 pm | N/A 2031-11-09 | KEMPHARM INC | KMPH | Pascoe Richard W Chairman | 100,000 | $0 | 100,000 (Direct) | View |
2021-08-20 Other | 2021-08-24 4:51 pm | N/A N/A | KEMPHARM INC | KMPH | Mickle Travis C CEO | 114,607 | $0 | 509,645 (Direct) | View |
2021-08-20 Option Award | 2021-08-24 4:51 pm | N/A 2031-08-19 | KEMPHARM INC | KMPH | Mickle Travis C CEO | 263,743 | $0 | 509,645 (Direct) | View |
2021-08-20 Option Award | 2021-08-24 4:49 pm | N/A 2031-08-19 | KEMPHARM INC | KMPH | Clifton R. LaDuane CFO | 82,423 | $0 | 82,423 (Direct) | View |
2021-08-20 Option Award | 2021-08-24 4:27 pm | N/A 2031-08-19 | KEMPHARM INC | KMPH | Sangiovanni Timothy J. VP | 44,023 | $0 | 44,023 (Direct) | View |
2021-08-20 Option Award | 2021-08-24 4:26 pm | N/A 2031-08-19 | KEMPHARM INC | KMPH | Guenther Sven VP | 81,716 | $0 | 81,716 (Direct) | View |
2021-08-18 Ownership | 2021-08-18 5:38 pm | N/A 2031-08-17 | KEMPHARM INC | KMPH | SEYMOUR TAMARA A Director | 0 | $0 | 22,500 (Direct) | View |
2021-06-17 Option Award | 2021-06-21 08:36 am | N/A 2031-06-16 | KEMPHARM INC | KMPH | Tierney David S Director | 15,000 | $0 | 15,000 (Direct) | View |
2021-06-17 Option Award | 2021-06-21 08:35 am | N/A 2031-06-16 | KEMPHARM INC | KMPH | Saluri Joseph Director | 15,000 | $0 | 15,000 (Direct) | View |
2021-06-17 Option Award | 2021-06-21 08:35 am | N/A 2031-06-16 | KEMPHARM INC | KMPH | Plooster Matthew R Director | 15,000 | $0 | 15,000 (Direct) | View |
2021-06-17 Option Award | 2021-06-21 08:35 am | N/A 2031-06-16 | KEMPHARM INC | KMPH | Pascoe Richard W Director | 15,000 | $0 | 15,000 (Direct) | View |
2021-05-10 Ownership | 2021-05-17 4:42 pm | N/A N/A | KEMPHARM INC | KMPH | Braun Samuel J 10% Owner | 0 | $0 | 3,145,000 (Direct) | View |
2020-06-19 Option Award | 2020-06-22 8:44 pm | N/A 2030-06-18 | KEMPHARM INC | KMPH | Tierney David S Director | 30,000 | $0 | 30,000 (Direct) | View |
2020-06-19 Option Award | 2020-06-22 8:43 pm | N/A 2030-06-18 | KEMPHARM INC | KMPH | Saluri Joseph Director | 30,000 | $0 | 30,000 (Direct) | View |
2020-06-19 Option Award | 2020-06-22 8:43 pm | N/A 2030-06-18 | KEMPHARM INC | KMPH | Plooster Matthew R Director | 30,000 | $0 | 30,000 (Direct) | View |
2020-06-19 Option Award | 2020-06-22 8:43 pm | N/A 2030-06-18 | KEMPHARM INC | KMPH | Pascoe Richard W Director | 30,000 | $0 | 30,000 (Direct) | View |